Amrize: BofA Global Research cuts price objective to $40.00 from $50.00
AMRZ•Related News
Protagonist Therapeutics CEO Patel joins fireside chats at two investment bank conferences
PTGX•
Minimed Group Inc <MMED.O>: UBS Raises Target Price to $28 from $25
MMED•
MongoDB, Inc. <MDB.O>: Rosenblatt Securities raises target price to $445 from $395
MDB•
Abeona Therapeutics management to present at H.C. Wainwright global investment conference
ABEO•
Williams-Sonoma Inc <WSM.N>: Argus Research raises target price to $250 from $230
WSM•